Abstract
Postoperative cognitive dysfunction (POCD; cognitive change associated with anesthesia and surgery) is one of the most serious long-term postoperative complications that occur in elderly patients. Dexmedetomidine (DEX) has been shown to be beneficial for improving outcomes of postoperative cognitive function. However, the exact mechanism underlying this role requires is yet to be found. The present study aims to determine the pathways involved in the protective effects of DEX against POCD in C57BL/6 J aged mice. DEX was administered after POCD modeling in C57BL/6 J aged mice. The cognitive function was evaluated after DEX treatment using novel object recognition, open field, and Y-maze tests. We also assessed its effects on neuron apoptosis and production of TNF-α and IL-1β in mouse brain tissues as well as expression levels of DNA damage-related proteins p53, p21, and γH2AX. Interactions between early growth response 1 (EGR1) and p53, microRNA (miR)-381, and EGR1 were identified by ChIP and luciferase reporter assays, and gain- and loss-of-function experiments were performed to confirm the involvement of their interaction in POCD. DEX administration attenuated hippocampal neuron apoptosis, neuroinflammation, DNA damage, and cognitive impairment in aged mice. miR-381 targeted EGR1 and disrupted its interaction with p53, leading to a decline in hippocampal neuron apoptosis, DNA damage, neuroinflammation, and cognitive impairment. Furthermore, DEX administration resulted in the enhancement of miR-381 expression and the subsequent inhibition of EGR1/p53 to protect against cognitive impairment in aged mice. Overall, these results indicate that DEX may have a potential neuroprotective effect against POCD via the miR-381/EGR1/p53 signaling, shedding light on the mechanisms involved in neuroprotection in POCD.
Similar content being viewed by others
Data Availability
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Devinney MJ, Mathew JP, Berger M (2018) Postoperative delirium and postoperative cognitive dysfunction: two sides of the same coin? Anesthesiology 129(3):389–391. https://doi.org/10.1097/ALN.0000000000002338
Austin CA, O’Gorman T, Stern E, Emmett D, Sturmer T, Carson S, Busby-Whitehead J (2019) Association between postoperative delirium and long-term cognitive function after major nonemergent surgery. JAMA Surg 154(4):328–334. https://doi.org/10.1001/jamasurg.2018.5093
Hood R, Budd A, Sorond FA, Hogue CW (2018) Peri-operative neurological complications. Anaesthesia 73(Suppl 1):67–75. https://doi.org/10.1111/anae.14142
Needham MJ, Webb CE, Bryden DC (2017) Postoperative cognitive dysfunction and dementia: what we need to know and do. Br J Anaesth 119(suppl_1):i115–i125. https://doi.org/10.1093/bja/aex354
Huang C, Chu JM, Liu Y, Chang RC, Wong GT (2018) Varenicline reduces DNA damage, tau mislocalization and post surgical cognitive impairment in aged mice. Neuropharmacology 143:217–227. https://doi.org/10.1016/j.neuropharm.2018.09.044
Bao N, Tang B (2020) Organ-protective effects and the underlying mechanism of dexmedetomidine. Mediators Inflamm 2020:6136105. https://doi.org/10.1155/2020/6136105
Hu J, Vacas S, Feng X, Lutrin D, Uchida Y, Lai IK, Maze M (2018) Dexmedetomidine prevents cognitive decline by enhancing resolution of high mobility group box 1 protein-induced inflammation through a vagomimetic action in mice. Anesthesiology 128(5):921–931. https://doi.org/10.1097/ALN.0000000000002038
Xue Y, Xu T, Jiang W (2020) Dexmedetomidine protects PC12 cells from ropivacaine injury through miR-381/LRRC4 /SDF-1/CXCR4 signaling pathway. Regen Ther 14:322–329. https://doi.org/10.1016/j.reth.2020.03.001
Omahen DA (2011) MicroRNA and diseases of the nervous system. Neurosurgery 69(2):440–454. https://doi.org/10.1227/NEU.0b013e318215a3b3
Zhan LY, Lei SQ, Zhang BH, Li WL, Wang HX, Zhao B, Cui SS, Ding H et al (2018) Overexpression of miR-381 relieves neuropathic pain development via targeting HMGB1 and CXCR4. Biomed Pharmacother 107:818–823. https://doi.org/10.1016/j.biopha.2018.08.053
Piao JM, Wu W, Yang ZX, Li YZ, Luo Q, Yu JL (2018) MicroRNA-381 favors repair of nerve injury through regulation of the SDF-1/CXCR4 signaling pathway via LRRC4 in acute cerebral ischemia after cerebral lymphatic blockage. Cell Physiol Biochem 46(3):890–906. https://doi.org/10.1159/000488821
Duclot F, Kabbaj M (2017) The role of early growth response 1 (EGR1) in brain plasticity and neuropsychiatric disorders. Front Behav Neurosci 11:35. https://doi.org/10.3389/fnbeh.2017.00035
Cong J, Wang C, Pu D, Liu J, Hu G, Gao C, Wu J (2014) Expression of early growth response 1 affects miR-106a/signal transducer and activator of transcription 3 regulating cognitive impairment in ovariectomized mice. Menopause 21(10):1143–1150. https://doi.org/10.1097/GME.0000000000000234
Ao H, Liu B, Li H, Lu L (2019) Egr1 mediates retinal vascular dysfunction in diabetes mellitus via promoting p53 transcription. J Cell Mol Med 23(5):3345–3356. https://doi.org/10.1111/jcmm.14225
Jazvinscak Jembrek M, Slade N, Hof PR, Simic G (2018) The interactions of p53 with tau and Ass as potential therapeutic targets for Alzheimer’s disease. Prog Neurobiol 168:104–127. https://doi.org/10.1016/j.pneurobio.2018.05.001
Qiu LL, Ji MH, Zhang H, Yang JJ, Sun XR, Tang H, Wang J, Liu WX et al (2016) NADPH oxidase 2-derived reactive oxygen species in the hippocampus might contribute to microglial activation in postoperative cognitive dysfunction in aged mice. Brain Behav Immun 51:109–118. https://doi.org/10.1016/j.bbi.2015.08.002
Chen Y, Sun JX, Chen WK, Wu GC, Wang YQ, Zhu KY, Wang J (2019) miR-124/VAMP3 is a novel therapeutic target for mitigation of surgical trauma-induced microglial activation. Signal Transduct Target Ther 4:27. https://doi.org/10.1038/s41392-019-0061-x
Bevins RA, Besheer J (2006) Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study ‘recognition memory.’ Nat Protoc 1(3):1306–1311. https://doi.org/10.1038/nprot.2006.205
Deiner S, Luo X, Lin HM, Sessler DI, Saager L, Sieber FE, Lee HB, Sano M et al (2017) Intraoperative infusion of dexmedetomidine for prevention of postoperative delirium and cognitive dysfunction in elderly patients undergoing major elective noncardiac surgery: a randomized clinical trial. JAMA Surg 152(8):e171505. https://doi.org/10.1001/jamasurg.2017.1505
Wang SL, Duan L, Xia B, Liu Z, Wang Y, Wang GM (2017) Dexmedetomidine preconditioning plays a neuroprotective role and suppresses TLR4/NF-kappaB pathways model of cerebral ischemia reperfusion. Biomed Pharmacother 93:1337–1342. https://doi.org/10.1016/j.biopha.2017.06.051
Boche D, Perry VH, Nicoll JA (2013) Review: activation patterns of microglia and their identification in the human brain. Neuropathol Appl Neurobiol 39(1):3–18. https://doi.org/10.1111/nan.12011
Bao Y, Zhu Y, He G, Ni H, Liu C, Ma L, Zhang L, Shi D (2019) Dexmedetomidine attenuates neuroinflammation in LPS-stimulated BV2 microglia cells through upregulation of miR-340. Drug Des Devel Ther 13:3465–3475. https://doi.org/10.2147/DDDT.S210511
He H, Zhou Y, Zhou Y, Zhuang J, He X, Wang S, Lin W (2018) Dexmedetomidine mitigates microglia-mediated neuroinflammation through upregulation of programmed cell death protein 1 in a rat spinal cord injury model. J Neurotrauma 35(21):2591–2603. https://doi.org/10.1089/neu.2017.5625
Qian XL, Zhang W, Liu MZ, Zhou YB, Zhang JM, Han L, Peng YM, Jiang JH et al (2015) Dexmedetomidine improves early postoperative cognitive dysfunction in aged mice. Eur J Pharmacol 746:206–212. https://doi.org/10.1016/j.ejphar.2014.11.017
Sun W, Zhao J, Li C (2020) Dexmedetomidine provides protection against hippocampal neuron apoptosis and cognitive impairment in mice with Alzheimer’s disease by mediating the miR-129/YAP1/JAG1 axis. Mol Neurobiol 57(12):5044–5055. https://doi.org/10.1007/s12035-020-02069-z
Kobayashi T, Otsuguro K, Yamaguchi S, Ito S (2015) Contribution of alpha2A-adrenoceptor subtype to effect of dexmedetomidine and xylazine on spinal synaptic transmission of mice. Eur J Pharmacol 761:321–329. https://doi.org/10.1016/j.ejphar.2015.06.020
Funai Y, Pickering AE, Uta D, Nishikawa K, Mori T, Asada A, Imoto K, Furue H (2014) Systemic dexmedetomidine augments inhibitory synaptic transmission in the superficial dorsal horn through activation of descending noradrenergic control: an in vivo patch-clamp analysis of analgesic mechanisms. Pain 155(3):617–628. https://doi.org/10.1016/j.pain.2013.12.018
Faber ES, Chambers JP, Evans RH (1998) Depression of NMDA receptor-mediated synaptic transmission by four alpha2 adrenoceptor agonists on the in vitro rat spinal cord preparation. Br J Pharmacol 124(3):507–512. https://doi.org/10.1038/sj.bjp.0701873
Liang H, Liu HZ, Wang HB, Zhong JY, Yang CX, Zhang B (2017) Dexmedetomidine protects against cisplatin-induced acute kidney injury in mice through regulating apoptosis and inflammation. Inflamm Res 66(5):399–411. https://doi.org/10.1007/s00011-017-1023-9
Cao C, Deng F, Hu Y (2020) Dexmedetomidine alleviates postoperative cognitive dysfunction through circular RNA in aged rats. 3 Biotech 10(4):176. https://doi.org/10.1007/s13205-020-2163-0
Ou HL, Schumacher B (2018) DNA damage responses and p53 in the aging process. Blood 131(5):488–495. https://doi.org/10.1182/blood-2017-07-746396
Brochier C, Dennis G, Rivieccio MA, McLaughlin K, Coppola G, Ratan RR, Langley B (2013) Specific acetylation of p53 by HDAC inhibition prevents DNA damage-induced apoptosis in neurons. J Neurosci 33(20):8621–8632. https://doi.org/10.1523/JNEUROSCI.5214-12.2013
Gong D, Zeng Z, Yi F, Wu J (2019) Inhibition of histone deacetylase 11 promotes human liver cancer cell apoptosis. Am J Transl Res 11(2):983–990
Liu S, Yao X, Zhang D, Sheng J, Wen X, Wang Q, Chen G, Li Z et al (2018) Analysis of transcription factor-related regulatory networks based on bioinformatics analysis and validation in hepatocellular carcinoma. Biomed Res Int 2018:1431396. https://doi.org/10.1155/2018/1431396
Yang W, Guo Q, Li J, Wang X, Pan B, Wang Y, Wu L, Yan J et al (2019) microRNA-124 attenuates isoflurane-induced neurological deficits in neonatal rats via binding to EGR1. J Cell Physiol 234(12):23017–23032. https://doi.org/10.1002/jcp.28862
Abella N, Brun S, Calvo M, Tapia O, Weber JD, Berciano MT, Lafarga M, Bachs O et al (2010) Nucleolar disruption ensures nuclear accumulation of p21 upon DNA damage. Traffic 11(6):743–755. https://doi.org/10.1111/j.1600-0854.2010.01063.x
Kim SJ, Kim JM, Shim SH, Chang HI (2014) Shikonin induces cell cycle arrest in human gastric cancer (AGS) by early growth response 1 (Egr1)-mediated p21 gene expression. J Ethnopharmacol 151(3):1064–1071. https://doi.org/10.1016/j.jep.2013.11.055
Zhou Q, Luo L, Wang X, Li X (2019) Relationship between single nucleotide polymorphisms in the 3’UTR of amyloid precursor protein and risk of Alzheimer’s disease and its mechanism. Biosci Rep 39(5):BSR20182485. https://doi.org/10.1042/BSR20182485
Xia LX, Ke C, Lu JM (2018) NEAT1 contributes to neuropathic pain development through targeting miR-381/HMGB1 axis in CCI rat models. J Cell Physiol 233(9):7103–7111. https://doi.org/10.1002/jcp.26526
Shi X, Yan C, Liu B, Yang C, Nie X, Wang X, Zheng J, Wang Y et al (2015) miR-381 regulates neural stem cell proliferation and differentiation via regulating Hes1 expression. PLoS ONE 10(10):e0138973. https://doi.org/10.1371/journal.pone.0138973
Zhang Y, Wang X, Liu Z, Yu L (2018) Dexmedetomidine attenuates lipopolysaccharide induced acute lung injury by targeting NLRP3 via miR-381. J Biochem Mol Toxicol 32(11):e22211. https://doi.org/10.1002/jbt.22211
Wan G, Mathur R, Hu X, Zhang X, Lu X (2011) miRNA response to DNA damage. Trends Biochem Sci 36(9):478–484. https://doi.org/10.1016/j.tibs.2011.06.002
Author information
Authors and Affiliations
Contributions
Yi-Liang Wang designed the study. Da-Sheng Cai was involved in data collection. Ying Zhang and Da-Sheng Cai performed the statistical analysis and preparation of figures. Yi-Liang Wang and Ying Zhang drafted the paper. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics Statement
This study was carried out after being approved by the ethics committee of the First Hospital of China Medical University and was performed according to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health. Extensive efforts were made to ensure minimal suffering of the animals used in the study.
Conflicts of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Wang, YL., Zhang, Y. & Cai, DS. Dexmedetomidine Ameliorates Postoperative Cognitive Dysfunction via the MicroRNA-381-Mediated EGR1/p53 Axis. Mol Neurobiol 58, 5052–5066 (2021). https://doi.org/10.1007/s12035-021-02417-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12035-021-02417-7